羟氯喹治疗新冠肺炎的临床药学监护要点思考
王志鹏， 廖赟， 翟晓波， 叶晓芬， 董平， 孟现民， 钟明康… - 药学进展, 2020 - pps.cpu.edu.cn
… 治疗COVID-19 患者,在全球范围引起了极大关注;《上海市2019 … of hydroxychloroquine in the
treatment of COVID-19. [Key words] … as a treatment of COVID-19: results of an openlabel non-…
treatment of COVID-19. [Key words] … as a treatment of COVID-19: results of an openlabel non-…
[PDF][PDF] SARS-CoV-2及其他β-冠状病毒相关呼吸系统疾病治疗措施的安全性系统评价与Meta分析*
张靖雪， 周庆欣， 曾雪扬， 杨智荣， 蔡先明， 蔡珊… - 医药导报, 2022 - yydbzz.com
… Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open
… with improved outcomes in patients with coronavirus disease 2019: a retrospective study [ …
… with improved outcomes in patients with coronavirus disease 2019: a retrospective study [ …
新型冠状病毒肺炎药物预防, 诊断, 治疗与出院管理循证临床实践指南(更新版)
靳英辉， 詹庆元， 彭志勇， 任学群， 尹训涛… - 解放军医学 …, 2020 - search.proquest.com
… , coronavirus disease 2019 (COVID-19), affecting more than seventeen million people … 前未
服用羟氯喹(hydroxychloroquine, HCQ)的人群相比,在接触第1例COVID-19患者之前服用HCQ,可…
服用羟氯喹(hydroxychloroquine, HCQ)的人群相比,在接触第1例COVID-19患者之前服用HCQ,可…
阿比多尔抗病毒研究进展.
白镓玮， 马承泰， 魏捷， 吴淼… - … & Analysis of Drug-Use in …, 2022 - search.ebscohost.com
… In China, arbidol is mainly used for the treatment of upper … disease patients infected by
coronavirus disease 2019 ( … oral steroid and hydroxychloroquine in a patient with systemic …
coronavirus disease 2019 ( … oral steroid and hydroxychloroquine in a patient with systemic …
[PDF][PDF] 新型冠状病毒感染传播, 发病机制, 诊断和治疗的进展
王业明， 徐逸天， 曹彬 - 中华结核和呼吸杂志, 2021 - upload.medlive.cn
… Clinical characteristics of coronavirus disease 2019 in China[… SARS‑CoV‑2 receptor ACE2
and TMPRSS2 are primarily … results of a randomised, controlled, open‑label, platform trial[J]. …
and TMPRSS2 are primarily … results of a randomised, controlled, open‑label, platform trial[J]. …